Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2026-01-24 @ 7:39 PM
Study NCT ID:
NCT04963595
Status:
UNKNOWN
Last Update Posted:
2021-07-15
First Post:
2021-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Sponsor:
Zhiyong Yu
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ShandongCHI-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None